Literature DB >> 17123871

Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment.

Jon Valla1, Lonnie Schneider, Tracy Niedzielko, Keith D Coon, Richard Caselli, Marwan N Sabbagh, Geoffrey L Ahern, Leslie Baxter, Gene Alexander, Douglas G Walker, Eric M Reiman.   

Abstract

Mitochondrial abnormalities are found in Alzheimer's disease (AD), but previous reports have not examined at-risk groups. In subjects with AD, mild cognitive impairment (MCI), and non-demented aged controls, platelet and lymphocyte mitochondria were isolated and analyzed for Complexes I, III, and IV of the electron transport chain. Western blots were used to control for differential enrichment of samples. Results demonstrated significant declines in Complexes III and IV in AD, and a significant decline in Complex IV in MCI. This report confirms mitochondrial deficiencies in AD, extends them to MCI, and suggests they are present at the earliest symptomatic stages of disease.

Entities:  

Mesh:

Year:  2006        PMID: 17123871      PMCID: PMC1864936          DOI: 10.1016/j.mito.2006.10.004

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  52 in total

1.  Tracking Alzheimer's disease in transgenic mice using fluorodeoxyglucose autoradiography.

Authors:  E M Reiman; A Uecker; F Gonzalez-Lima; D Minear; K Chen; N L Callaway; J D Berndt; D Games
Journal:  Neuroreport       Date:  2000-04-07       Impact factor: 1.837

Review 2.  What do mitochondrial diseases teach us about normal mitochondrial functions...that we already knew: threshold expression of mitochondrial defects.

Authors:  J P Mazat; R Rossignol; M Malgat; C Rocher; B Faustin; T Letellier
Journal:  Biochim Biophys Acta       Date:  2001-03-01

Review 3.  In vivo and in organello assessment of OXPHOS activities.

Authors:  Antoni Barrientos
Journal:  Methods       Date:  2002-04       Impact factor: 3.608

4.  Mitochondrial abnormalities in Alzheimer's disease.

Authors:  K Hirai; G Aliev; A Nunomura; H Fujioka; R L Russell; C S Atwood; A B Johnson; Y Kress; H V Vinters; M Tabaton; S Shimohama; A D Cash; S L Siedlak; P L Harris; P K Jones; R B Petersen; G Perry; M A Smith
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

5.  Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease.

Authors:  E M Reiman; R J Caselli; K Chen; G E Alexander; D Bandy; J Frost
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

6.  Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease.

Authors:  Alessandro Padovani; Barbara Borroni; Francesca Colciaghi; Carla Pettenati; Elisabetta Cottini; Chiara Agosti; Gian Luigi Lenzi; Carlo Caltagirone; Marco Trabucchi; Flaminio Cattabeni; Monica Di Luca
Journal:  Arch Neurol       Date:  2002-01

7.  Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines.

Authors:  P A Trimmer; R H Swerdlow; J K Parks; P Keeney; J P Bennett; S W Miller; R E Davis; W D Parker
Journal:  Exp Neurol       Date:  2000-03       Impact factor: 5.330

8.  Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration.

Authors:  J Valla; J D Berndt; F Gonzalez-Lima
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

9.  Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease.

Authors:  Francesca Bosetti; Francesca Brizzi; Silvia Barogi; Michelangelo Mancuso; Gabriele Siciliano; Elisabetta A Tendi; Luigi Murri; Stanley I Rapoport; Giancarlo Solaini
Journal:  Neurobiol Aging       Date:  2002 May-Jun       Impact factor: 4.673

Review 10.  Platelets as a peripheral district where to study pathogenetic mechanisms of alzheimer disease: the case of amyloid precursor protein.

Authors:  M Di Luca; F Colciaghi; L Pastorino; B Borroni; A Padovani; F Cattabeni
Journal:  Eur J Pharmacol       Date:  2000-09-29       Impact factor: 4.432

View more
  81 in total

Review 1.  Role of mitochondrial homeostasis and dynamics in Alzheimer's disease.

Authors:  J Eva Selfridge; Lezi E; Jianghua Lu; Russell H Swerdlow
Journal:  Neurobiol Dis       Date:  2012-01-10       Impact factor: 5.996

Review 2.  The Alzheimer's disease mitochondrial cascade hypothesis.

Authors:  Russell H Swerdlow; Jeffrey M Burns; Shaharyar M Khan
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 3.  Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.

Authors:  Xiongwei Zhu; George Perry; Mark A Smith; Xinglong Wang
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

4.  PET sheds light on Alzheimer's disease genetic risk.

Authors:  Russell H Swerdlow
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-19       Impact factor: 11.205

Review 5.  Estrogen: a master regulator of bioenergetic systems in the brain and body.

Authors:  Jamaica R Rettberg; Jia Yao; Roberta Diaz Brinton
Journal:  Front Neuroendocrinol       Date:  2013-08-29       Impact factor: 8.606

Review 6.  Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.

Authors:  L Holper; D Ben-Shachar; J J Mann
Journal:  Neuropsychopharmacology       Date:  2018-05-16       Impact factor: 7.853

Review 7.  Mitochondrial approaches for neuroprotection.

Authors:  Rajnish K Chaturvedi; M Flint Beal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 8.  Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.

Authors:  Lan Guo; Jing Tian; Heng Du
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 9.  Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention.

Authors:  Diana F Silva; J Eva Selfridge; Jianghua Lu; Lezi E; Sandra M Cardoso; Russell H Swerdlow
Journal:  Adv Pharmacol       Date:  2012

Review 10.  Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease.

Authors:  Jia Yao; Roberta Diaz Brinton
Journal:  Adv Pharmacol       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.